Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Raptor Pharmaceuticals Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Raptor Pharmaceuticals Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Re Yon Pharmaceutical Co., Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Re Yon Pharmaceutical Co., Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Read-Gene SA - Business Profile with Financial and SWOT Analysis

US$ 200.00

Read-Gene SA - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Recordati SpA - Business Profile with Financial and SWOT Analysis

US$ 200.00

Recordati SpA - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Redpoint Bio Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Redpoint Bio Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Reflect Scientific, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Reflect Scientific, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

ReGen Biologics Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

ReGen Biologics Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

ReGen Therapeutics plc - Business Profile with Financial and SWOT Analysis

US$ 200.00

ReGen Therapeutics plc - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Regeneron Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Regeneron Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Regenerx Biopharmaceuticals Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Regenerx Biopharmaceuticals Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Regenicin, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Regenicin, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Reliance GeneMedix plc - Business Profile with Financial and SWOT Analysis

US$ 200.00

Reliance GeneMedix plc - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

ReNeuron Group plc - Business Profile with Financial and SWOT Analysis

US$ 200.00

ReNeuron Group plc - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Renhe Pharmacy Co., Ltd - Business Profile with Financial and SWOT Analysis

US$ 200.00

Renhe Pharmacy Co., Ltd - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Renovo Group plc - Business Profile with Financial and SWOT Analysis

US$ 200.00

Renovo Group plc - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Repligen Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Repligen Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Repros Therapeutics Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Repros Therapeutics Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Response Genetics, Inc - Business Profile with Financial and SWOT Analysis

US$ 200.00

Response Genetics, Inc - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Resverlogix Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Resverlogix Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Rexahn Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Rexahn Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Reyoung Pharmaceutical Holdings Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Reyoung Pharmaceutical Holdings Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Rigas Farmaceitiska Fabrika - Business Profile with Financial and SWOT Analysis

US$ 200.00

Rigas Farmaceitiska Fabrika - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Rigel Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Rigel Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

RNL Bio Co., Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

RNL Bio Co., Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Roche Holding AG - Business Profile with Financial and SWOT Analysis

US$ 200.00

Roche Holding AG - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Rockwall Holdings, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Rockwall Holdings, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Rohto Pharmaceutical Co. Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Rohto Pharmaceutical Co. Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Rosetta Genomics, Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Rosetta Genomics, Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

RPG Life Sciences Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

RPG Life Sciences Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Rubicon Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Rubicon Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

RxElite Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

RxElite Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

RXi Pharmaceuticals Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

RXi Pharmaceuticals Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Saamya Biotech (India) Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Saamya Biotech (India) Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Salix Pharmaceuticals Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Salix Pharmaceuticals Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Sam-A Pharm. Co. Ltd - Business Profile with Financial and SWOT Analysis

US$ 200.00

Sam-A Pharm. Co. Ltd - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Sam Chun Dang Pharmacy - Business Profile with Financial and SWOT Analysis

US$ 200.00

Sam Chun Dang Pharmacy - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Samaritan Pharmaceuticals Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Samaritan Pharmaceuticals Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Samil Pharmaceutical Co. Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Samil Pharmaceutical Co. Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Samjin Pharmaceutical Co. Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Samjin Pharmaceutical Co. Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Samsung Pharmaceutical Industry Corp. Ltd.. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Samsung Pharmaceutical Industry Corp. Ltd.. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Sandu Pharmaceuticals Ltd - Business Profile with Financial and SWOT Analysis

US$ 200.00

Sandu Pharmaceuticals Ltd - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Sangamo Biosciences Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Sangamo Biosciences Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Sangui Biotech International Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Sangui Biotech International Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Sanguine Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Sanguine Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Sanitas AB - Business Profile with Financial and SWOT Analysis

US$ 200.00

Sanitas AB - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Sanjivani Paranteral Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Sanjivani Paranteral Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Sanochemia Pharmazeutika AG - Business Profile with Financial and SWOT Analysis

US$ 200.00

Sanochemia Pharmazeutika AG - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Sanofi Aventis Pakistan Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Sanofi Aventis Pakistan Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Sanofi-Aventis - Business Profile with Financial and SWOT Analysis

US$ 200.00

Sanofi-Aventis - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Santarus Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Santarus Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1